AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $191.65 million. The enterprise value is $209.91 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 26.43 million shares outstanding. The number of shares has increased by 2.35% in one year.
| Current Share Class | 26.43M |
| Shares Outstanding | 26.43M |
| Shares Change (YoY) | +2.35% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 23.35% |
| Float | 25.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.63 |
| Forward PS | 1.83 |
| PB Ratio | -41.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09
| Current Ratio | 2.09 |
| Quick Ratio | 1.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.24 |
Financial Efficiency
Return on equity (ROE) is -407.50% and return on invested capital (ROIC) is -54.81%.
| Return on Equity (ROE) | -407.50% |
| Return on Assets (ROA) | -38.35% |
| Return on Invested Capital (ROIC) | -54.81% |
| Return on Capital Employed (ROCE) | -109.90% |
| Revenue Per Employee | $275,619 |
| Profits Per Employee | -$219,408 |
| Employee Count | 260 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.34 |
Taxes
In the past 12 months, AVITA Medical has paid $32,000 in taxes.
| Income Tax | 32,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.23% in the last 52 weeks. The beta is 1.74, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.74 |
| 52-Week Price Change | -12.23% |
| 50-Day Moving Average | 8.85 |
| 200-Day Moving Average | 10.09 |
| Relative Strength Index (RSI) | 31.99 |
| Average Volume (20 Days) | 250,691 |
Short Selling Information
| Short Interest | 2.97M |
| Short Previous Month | 2.79M |
| Short % of Shares Out | 10.65% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 13.78 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $71.66 million and -$57.05 million in losses. Loss per share was -$2.19.
| Revenue | 71.66M |
| Gross Profit | 61.25M |
| Operating Income | -51.21M |
| Pretax Income | -49.74M |
| Net Income | -57.05M |
| EBITDA | -49.77M |
| EBIT | -51.21M |
| Loss Per Share | -$2.19 |
Full Income StatementBalance Sheet
The company has $25.82 million in cash and $44.07 million in debt, giving a net cash position of -$18.26 million or -$0.69 per share.
| Cash & Cash Equivalents | 25.82M |
| Total Debt | 44.07M |
| Net Cash | -18.26M |
| Net Cash Per Share | -$0.69 |
| Equity (Book Value) | -4.57M |
| Book Value Per Share | -0.17 |
| Working Capital | 25.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.38 million and capital expenditures -$8.25 million, giving a free cash flow of -$46.63 million.
| Operating Cash Flow | -38.38M |
| Capital Expenditures | -8.25M |
| Free Cash Flow | -46.63M |
| FCF Per Share | -$1.76 |
Full Cash Flow StatementMargins
Gross margin is 85.47%, with operating and profit margins of -71.47% and -79.61%.
| Gross Margin | 85.47% |
| Operating Margin | -71.47% |
| Pretax Margin | -79.56% |
| Profit Margin | -79.61% |
| EBITDA Margin | -69.45% |
| EBIT Margin | -71.47% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.35% |
| Shareholder Yield | -2.35% |
| Earnings Yield | -29.77% |
| FCF Yield | -24.33% |
Analyst Forecast
The average price target for AVITA Medical is $17.25, which is 137.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.25 |
| Price Target Difference | 137.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 41.99% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
AVITA Medical has an Altman Z-Score of -6.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.37 |
| Piotroski F-Score | 3 |